Pharmaceuticals in Indonesia - Market Summary, Competitive Analysis and Forecast, 2016-2025

Pharmaceuticals in Indonesia - Market Summary, Competitive Analysis and Forecast, 2016-2025

Summary

Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Indonesian pharmaceuticals market had total revenues of $5.0bn in 2020, representing a compound annual rate of change (CARC) of -0.1% between 2016 and 2020.
  • High levels of public debt and a contracting economy in Indonesia in 2020 is likely to put significant pressure on government spending, meaning that there is limited space for crucial infrastructure spending to support the pharmaceutical market.
  • The increasing threat of competition from India and China, as manufacturing and export capacity is increased in these countries, could act as a barrier to growth in the Indonesian market.


  • Scope
    • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Indonesia
    • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Indonesia
    • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
    • Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia pharmaceuticals market with five year forecasts by both value and volume
    Reasons to Buy
    • What was the size of the Indonesia pharmaceuticals market by value in 2020?
    • What will be the size of the Indonesia pharmaceuticals market in 2025?
    • What factors are affecting the strength of competition in the Indonesia pharmaceuticals market?
    • How has the market performed over the last five years?
    • Who are the top competitors in Indonesia's pharmaceuticals market?


    1 Executive Summary
    1.1. Market value
    1.2. Market value forecast
    1.3. Geography segmentation
    1.4. Market share
    1.5. Market rivalry
    1.6. Competitive Landscape
    2 Market Overview
    2.1. Market definition
    2.2. Market analysis
    3 Market Data
    3.1. Market value
    4 Market Segmentation
    4.1. Geography segmentation
    5 Market Outlook
    5.1. Market value forecast
    6 Five Forces Analysis
    6.1. Summary
    6.2. Buyer power
    6.3. Supplier power
    6.4. New entrants
    6.5. Threat of substitutes
    6.6. Degree of rivalry
    7 Competitive Landscape
    7.1. Market share
    7.2. Who are the leading players?
    7.3. Are there any other notable players in the market?
    7.4. What are the strengths of leading players?
    7.5. What strategies do leading players follow?
    8 Company Profiles
    8.1. Sanofi SA
    8.2. PT Kimia Farma Tbk
    8.3. Novartis AG
    9 Macroeconomic Indicators
    9.1. Country data
    10 Appendix
    10.1. Methodology
    10.2. Industry associations
    10.3. Related MarketLine research
    10.4. About MarketLine
    List of Tables
    Table 1: Indonesia pharmaceuticals market value: $ billion, 2016-20
    Table 2: Indonesia pharmaceuticals market geography segmentation: $ billion, 2020
    Table 3: Indonesia pharmaceuticals market value forecast: $ billion, 2020-25
    Table 4: Indonesia pharmaceuticals market share: % share, by value, 2020
    Table 5: Sanofi SA: key facts
    Table 6: Sanofi SA: Annual Financial Ratios
    Table 7: Sanofi SA: Key Employees
    Table 8: Sanofi SA: Key Employees Continued
    Table 9: PT Kimia Farma Tbk: key facts
    Table 10: PT Kimia Farma Tbk: Annual Financial Ratios
    Table 11: PT Kimia Farma Tbk: Key Employees
    Table 12: Novartis AG: key facts
    Table 13: Novartis AG: Annual Financial Ratios
    Table 14: Novartis AG: Key Employees
    Table 15: Novartis AG: Key Employees Continued
    Table 16: Indonesia size of population (million), 2016-20
    Table 17: Indonesia gdp (constant 2005 prices, $ billion), 2016-20
    Table 18: Indonesia gdp (current prices, $ billion), 2016-20
    Table 19: Indonesia inflation, 2016-20
    Table 20: Indonesia consumer price index (absolute), 2016-20
    Table 21: Indonesia exchange rate, 2016-20
    List of Figures
    Figure 1: Indonesia pharmaceuticals market value: $ billion, 2016-20
    Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2020
    Figure 3: Indonesia pharmaceuticals market value forecast: $ billion, 2020-25
    Figure 4: Forces driving competition in the pharmaceuticals market in Indonesia, 2020
    Figure 5: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2020
    Figure 6: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2020
    Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2020
    Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2020
    Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2020
    Figure 10: Indonesia pharmaceuticals market share: % share, by value, 2020

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings